31.05.2010 • News

Arkema Inc. Receives Regulatory Approval to Market its Carbon Nanotubes in the U.S.

Arkema has announced that it now has received Environmental Protection Agency (EPA) approval for commercial sales of its Graphistrength multiwall carbon nanotubes (CNTs) in the U.S.

This approval gives the green light to Arkema Inc., Arkema's U.S. subsidiary, to assist its existing and prospective customers in the U.S. currently conducting research and application tests involving CNTs with their commercial development on a larger scale. The company said they expect to see a boost in the worldwide sales of its Graphistrength masterbatches, which are already available in Europe and Asia.

Since it first began producing CNTs in 2006, Arkema has sought to develop a whole range of high added-value masterbatches designed to optimize the performance of CNTs in polymer matrices (thermoplastic, elastomer and thermoset).

In September 2009, Arkema announced the construction of a 400 t/y CNT pilot production plant in France. The plant is due to come on stream early 2011.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read